Search hospitals > Texas > San Antonio
Novartis Investigative Site
Claim this profileSan Antonio, Texas 78229
Global Leader in Postoperative Pain
Global Leader in Multiple Sclerosis
Conducts research for Systemic Sclerosis
Conducts research for Diabetes
Conducts research for Fatty Liver
174 reported clinical trials
8 medical researchers
Summary
Novartis Investigative Site is a medical facility located in San Antonio, Texas. This center is recognized for care of Postoperative Pain, Multiple Sclerosis, Systemic Sclerosis, Diabetes, Fatty Liver and other specialties. Novartis Investigative Site is involved with conducting 174 clinical trials across 149 conditions. There are 8 research doctors associated with this hospital, such as Nitendra Agarwal, Grant Garbo, MD, Hernan Alfonso Salazar, and EMANUEL PHILIP DE NOIA.Top PIs
Nitendra AgarwalEndeavor Clinical Trials1 year of reported clinical research
Studies Obesity
Studies Childhood Obesity
8 reported clinical trials
10 drugs studied
Grant Garbo, MDEndeavor Clinical Trials2 years of reported clinical research
Studies Chronic Kidney Disease
Studies Anemia
2 reported clinical trials
4 drugs studied
Hernan Alfonso SalazarEndeavor Clinical Trials5 years of reported clinical research
Studies Fatty Liver
Studies Non-alcoholic Fatty Liver Disease
2 reported clinical trials
3 drugs studied
EMANUEL PHILIP DE NOIAEndeavor Clinical Trials2 years of reported clinical research
Studies Hypertriglyceridemia
Studies High Triglycerides
1 reported clinical trial
2 drugs studied
Clinical Trials running at Novartis Investigative Site
Obesity
Cardiovascular Disease
Gout
Chronic Urticaria
Chronic Kidney Disease
Childhood Obesity
Type 2 Diabetes
Multiple Sclerosis
Atherosclerosis
Contrast-induced Nephropathy
LY3305677
for Obesity
The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The CWMM establishes entry criteria for newly enrolled participants across the master and the ISAs. The ISAs may start independently of other ISAs as interventions become available for clinical testing. The results for the CWMM screening record will be reported when all the ISA's complete.
Recruiting0 awards Phase 23 criteria
LY3841136 + Tirzepatide
for Obesity with Type 2 Diabetes
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to investigate the safety and efficacy of LY3841136 for chronic weight management alone or in combination with Tirzepatide across a wide dose range in participants with Type 2 Diabetes. Participation in the study will last about 64 weeks.
Recruiting0 awards Phase 2
LY4086940
for Obesity
The main purpose of this study is to evaluate the safety, tolerability of LY4086940 and how it is processed in the body. Participation in Part A of the study will last about 10 weeks and may include up to 6 visits. Participation in Parts B, C, D will last approximately 15 weeks and may include up to 9 visits.
Recruiting0 awards Phase 11 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in San Antonio, Texas. This center is recognized for care of Postoperative Pain, Multiple Sclerosis, Systemic Sclerosis, Diabetes, Fatty Liver and other specialties. Novartis Investigative Site is involved with conducting 174 clinical trials across 149 conditions. There are 8 research doctors associated with this hospital, such as Nitendra Agarwal, Grant Garbo, MD, Hernan Alfonso Salazar, and EMANUEL PHILIP DE NOIA.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.